Search for: "CIPLA"
Results 181 - 200
of 202
Sorted by Relevance
|
Sort by Date
1 Dec 2007, 9:00 am
: (IPDragon), China Bad News For Thailand's Counterfeit Manufacturers: (IPDragon), Software and IP again: (China Hearsay),Consortium of 5 Hollywood studios is suing jetboo.com and Eastday Bar in China for copyright infringement in relation to movies in internet cafes: (IPKat),Formation of the WTO panel requested by the US on China's distribution of copyrighted material was delayed after a procedural move on an unrelated matter: (IPWatch),One-third of European companies in China have no IP… [read post]
14 Dec 2007, 1:00 am
: (Patent Prospector) PharmaAggregate launches new online presence: (MaRS Blog - Innovation and Commercialization in Canada)Japan Plans Generic Drug Incentives to Cut Down Medical Costs: (MedIndia), Interesting commentary and article on generic/ innovator company patent settlements: (Generic Pharmaceuticals & IP), Global trends in commencement of patent actions by innovators: (Generic Pharmaceuticals & IP), Is marketing and not … [read post]
10 Sep 2012, 10:08 pm
Cipla Ltd., 681 F.3d 1283, 1299-1301 (Fed. [read post]
25 Nov 2009, 3:00 am
(Patents4Life) R&D: the biggest spenders – discussion of 2009 EU Industrial R&D Scoreboard (IPKat) New search tool by OHIM and participating offices (Class 46) EPO – Many more changes coming next year (IPKat) EU-South Korea Free Trade Agreement: For the first time in a bilateral agreement between EU and a third country, the EU provides for the protection of European geographical indications (Class 46) Three more PGI regulations in force: Limone Interdonato Messina, Proscuitto di… [read post]
9 May 2008, 10:30 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
1 Feb 2008, 12:00 am
, (Intellectual Property Watch), (Out-Law), (Electronic Frontier Foundation), The UK High Court allows computer program patent claims in Astron Clinica & Ors v The Comptroller: (IPKat), (BLOG@IP::JUR), (Filemot), (IAM), (The IP Factor), (IP Updates), (IMPACT), (IPcentral Weblog), (Out-Law), (IPBiz),Tarceva (Erlotinib) - Roche patent infringement action against CIPLA before Delhi High Court: Many posts at: (Spicy … [read post]
18 Apr 2008, 2:00 am
: RealNetworks, Mattel and Hasbro copy the infringer by creating online Scrabble: (IP ThinkTank), Creative Commons Statement of Intent for Attribution-Share Alike Licenses released: (creativecommons.org) Events IP Business Congress – 25-26 June, Amsterdam: (IP Business Congress), INTA annual meeting – 17-21 May, Berlin: (IMPACT), Australia: IPRIA / CELRL / IP Australia: Employees’ IP and the employment relationship – incentives to innovate… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in 2007:… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
16 Jan 2009, 7:00 am
(Spicy IP) Global credit crisis leads to boom times for legal process outsourcing businesses specialising in IP (Spicy IP) Israel Israeli bakery Matzot Aviv files trade mark infringement suit against rival Patisserie Aviv and US importer Bagel Bites (The IP Factor) Israel Patent Office relaxes conditions for modified examination (The IP Factor) Italy Italian Supreme Court recognises ‘post sale confusion’ in criminal proceedings concerning sales of… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning the… [read post]
22 Feb 2008, 6:00 pm
: (Patent Baristas),Vietnam : new developments in patent protection for medical uses: (Patent Docs),Wisconsin Alumni Research Foundation licenses stem cell patents to BioTime: (IPBiz)Pharma & Biotech - ProductsFloxin (Ofloxacin) –US Supreme Court declines Daiichi Sankyo’s request for appeal of CAFC decision reversing Daichii’s initial win in its ofloxacin patent infringement case against Apotex: (IP Law360),Galvus (Vildagliptin) – Indian patent granted… [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
9 Aug 2008, 1:50 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
29 Aug 2008, 1:25 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
